Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that it attached schedule of Investors/Analysts meeting with the Company. There will not be any presentation at the Meeting. Also, no Unpublished Price Sensitive Information pertaining to the Company will be shared during this Meeting. The said intimation is also available on the website of the Company at www.abbott.co.in.
The above information is a part of company’s filings submitted to BSE.
